BioSource, Keystone Laboratories Inc. deal

BIOI completed the acquisition of Keystone for 500,000 shares of BIOI. The new Keystone Division of BIOI will continue to manufacture custom oligonucleotides. BIOI, which closed at $3.75 on Friday, ha...